001     139309
005     20240321220609.0
024 7 _ |a 10.1084/jem.20160933
|2 doi
024 7 _ |a pmid:28465465
|2 pmid
024 7 _ |a pmc:PMC5460996
|2 pmc
024 7 _ |a 0022-1007
|2 ISSN
024 7 _ |a 1540-9358
|2 ISSN
024 7 _ |a 1540-9538
|2 ISSN
024 7 _ |a altmetric:19847353
|2 altmetric
037 _ _ |a DZNE-2020-05631
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Stutz, Andrea
|b 0
245 _ _ |a NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain.
260 _ _ |a New York, NY
|c 2017
|b Rockefeller Univ. Press
264 _ 1 |3 online
|2 Crossref
|b Rockefeller University Press
|c 2017-05-02
264 _ 1 |3 print
|2 Crossref
|b Rockefeller University Press
|c 2017-06-05
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1591372938_14981
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a NLRP3 is a cytosolic pattern recognition receptor that senses microbes and endogenous danger signals. Upon activation, NLRP3 forms an inflammasome with the adapter ASC, resulting in caspase-1 activation, release of proinflammatory cytokines and cell death. How NLRP3 activation is regulated by transcriptional and posttranslational mechanisms to prevent aberrant activation remains incompletely understood. Here, we identify three conserved phosphorylation sites in NLRP3 and demonstrate that NLRP3 activation is controlled by phosphorylation of its pyrin domain (PYD). Phosphomimetic residues in NLRP3 PYD abrogate inflammasome activation and structural modeling indicates that phosphorylation of the PYD regulates charge-charge interaction between two PYDs that are essential for NLRP3 activation. Phosphatase 2A (PP2A) inhibition or knock-down drastically reduces NLRP3 activation, showing that PP2A can license inflammasome assembly via dephosphorylating NLRP3 PYD. These results propose that the balance between kinases and phosphatases acting on the NLRP3 PYD is critical for NLRP3 activation.
536 _ _ |a 342 - Disease Mechanisms and Model Systems (POF3-342)
|0 G:(DE-HGF)POF3-342
|c POF3-342
|f POF III
|x 0
542 _ _ |i 2019-09-19
|2 Crossref
|u http://www.rupress.org/terms/
542 _ _ |i 2017-12-04
|2 Crossref
|u https://creativecommons.org/licenses/by-nc-sa/4.0/
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Inflammasomes
|2 NLM Chemicals
650 _ 7 |a NLR Family, Pyrin Domain-Containing 3 Protein
|2 NLM Chemicals
650 _ 7 |a Nlrp3 protein, mouse
|2 NLM Chemicals
650 _ 7 |a Pyrin
|2 NLM Chemicals
650 _ 7 |a Phosphoserine
|0 17885-08-4
|2 NLM Chemicals
650 _ 7 |a Protein Phosphatase 2
|0 EC 3.1.3.16
|2 NLM Chemicals
650 _ 2 |a Amino Acid Sequence
|2 MeSH
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a HEK293 Cells
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Inflammasomes: metabolism
|2 MeSH
650 _ 2 |a Mice
|2 MeSH
650 _ 2 |a Models, Biological
|2 MeSH
650 _ 2 |a Models, Molecular
|2 MeSH
650 _ 2 |a NLR Family, Pyrin Domain-Containing 3 Protein: chemistry
|2 MeSH
650 _ 2 |a NLR Family, Pyrin Domain-Containing 3 Protein: metabolism
|2 MeSH
650 _ 2 |a Phosphorylation
|2 MeSH
650 _ 2 |a Phosphoserine: metabolism
|2 MeSH
650 _ 2 |a Protein Binding
|2 MeSH
650 _ 2 |a Protein Domains
|2 MeSH
650 _ 2 |a Protein Phosphatase 2: metabolism
|2 MeSH
650 _ 2 |a Pyrin: chemistry
|2 MeSH
650 _ 2 |a Structure-Activity Relationship
|2 MeSH
700 1 _ |a Kolbe, Carl-Christian
|b 1
700 1 _ |a Stahl, Rainer
|b 2
700 1 _ |a Horvath, Gabor L
|b 3
700 1 _ |a Franklin, Bernardo S
|0 P:(DE-HGF)0
|b 4
700 1 _ |a van Ray, Olivia
|b 5
700 1 _ |a Brinkschulte, Rebecca
|b 6
700 1 _ |a Geyer, Matthias
|b 7
700 1 _ |a Meissner, Felix
|b 8
700 1 _ |a Latz, Eicke
|0 P:(DE-2719)2000062
|b 9
|e Last author
|u dzne
773 1 8 |a 10.1084/jem.20160933
|b : Rockefeller University Press, 2017-05-02
|n 6
|p 1725-1736
|3 journal-article
|2 Crossref
|t Journal of Experimental Medicine
|v 214
|y 2017
|x 0022-1007
773 _ _ |a 10.1084/jem.20160933
|g Vol. 214, no. 6, p. 1725 - 1736
|0 PERI:(DE-600)1477240-1
|n 6
|q 214:6<1725 - 1736
|p 1725-1736
|t Journal of experimental medicine
|v 214
|y 2017
|x 0022-1007
856 7 _ |2 Pubmed Central
|u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460996
909 C O |o oai:pub.dzne.de:139309
|p VDB
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 9
|6 P:(DE-2719)2000062
913 1 _ |a DE-HGF
|b Forschungsbereich Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-342
|2 G:(DE-HGF)POF3-300
|v Disease Mechanisms and Model Systems
|x 0
914 1 _ |y 2017
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J EXP MED : 2021
|d 2022-11-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-13
915 _ _ |a IF >= 15
|0 StatID:(DE-HGF)9915
|2 StatID
|b J EXP MED : 2021
|d 2022-11-13
920 1 _ |0 I:(DE-2719)1013024
|k AG Latz
|l Innate Immunity in Neurodegeneration
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1013024
980 _ _ |a UNRESTRICTED
999 C 5 |a 10.1074/jbc.M111.278812
|9 -- missing cx lookup --
|2 Crossref
|o 10.1074/jbc.M111.278812
999 C 5 |a 10.1073/pnas.181342398
|9 -- missing cx lookup --
|2 Crossref
|o 10.1073/pnas.181342398
999 C 5 |a 10.4049/jimmunol.0901363
|9 -- missing cx lookup --
|2 Crossref
|o 10.4049/jimmunol.0901363
999 C 5 |a 10.1093/nar/16.22.10881
|9 -- missing cx lookup --
|2 Crossref
|o 10.1093/nar/16.22.10881
999 C 5 |a 10.1038/nbt.1511
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/nbt.1511
999 C 5 |a 10.1021/pr101065j
|9 -- missing cx lookup --
|2 Crossref
|o 10.1021/pr101065j
999 C 5 |a 10.1038/ni.2784
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/ni.2784
999 C 5 |a 10.1107/S0907444904019158
|9 -- missing cx lookup --
|2 Crossref
|o 10.1107/S0907444904019158
999 C 5 |a 10.4049/jimmunol.0900173
|9 -- missing cx lookup --
|2 Crossref
|o 10.4049/jimmunol.0900173
999 C 5 |a 10.1038/ni.2913
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/ni.2913
999 C 5 |a 10.1016/j.tcb.2014.05.001
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.tcb.2014.05.001
999 C 5 |a 10.1016/j.immuni.2016.09.008
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.immuni.2016.09.008
999 C 5 |a 10.4049/jimmunol.1202479
|9 -- missing cx lookup --
|2 Crossref
|o 10.4049/jimmunol.1202479
999 C 5 |a 10.1038/ni.1631
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/ni.1631
999 C 5 |a 10.1038/nature07725
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/nature07725
999 C 5 |a 10.1074/jbc.M109.082305
|9 -- missing cx lookup --
|2 Crossref
|o 10.1074/jbc.M109.082305
999 C 5 |a 10.1074/jbc.M112.407130
|9 -- missing cx lookup --
|2 Crossref
|o 10.1074/jbc.M112.407130
999 C 5 |a 10.1038/nri3452
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/nri3452
999 C 5 |a 10.1016/j.cell.2014.02.008
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.cell.2014.02.008
999 C 5 |a 10.1002/eji.201142079
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/eji.201142079
999 C 5 |a 10.1128/JVI.06543-11
|9 -- missing cx lookup --
|2 Crossref
|o 10.1128/JVI.06543-11
999 C 5 |a 10.1038/cr.2013.6
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/cr.2013.6
999 C 5 |a 10.1126/scitranslmed.aaf1471
|9 -- missing cx lookup --
|2 Crossref
|o 10.1126/scitranslmed.aaf1471
999 C 5 |a 10.1006/bbrc.2000.4190
|9 -- missing cx lookup --
|2 Crossref
|o 10.1006/bbrc.2000.4190
999 C 5 |a 10.1093/nar/gkt376
|9 -- missing cx lookup --
|2 Crossref
|o 10.1093/nar/gkt376
999 C 5 |a 10.1038/ni.2474
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/ni.2474
999 C 5 |a 10.1021/bi048374i
|9 -- missing cx lookup --
|2 Crossref
|o 10.1021/bi048374i
999 C 5 |a 10.1038/ni.3538
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/ni.3538
999 C 5 |a 10.1016/j.molcel.2012.11.009
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.molcel.2012.11.009
999 C 5 |y 2011
|2 Crossref
|t R: A Language and Environment for Statistical Computing.
|o R Development Core Team R: A Language and Environment for Statistical Computing. 2011
999 C 5 |a 10.1074/mcp.M114.043489
|9 -- missing cx lookup --
|2 Crossref
|o 10.1074/mcp.M114.043489
999 C 5 |a 10.1038/nmeth.2019
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/nmeth.2019
999 C 5 |a 10.1084/jem.20151790
|9 -- missing cx lookup --
|2 Crossref
|o 10.1084/jem.20151790
999 C 5 |a 10.1172/JCI83669
|9 -- missing cx lookup --
|2 Crossref
|o 10.1172/JCI83669
999 C 5 |a 10.1038/nature10759
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/nature10759
999 C 5 |a 10.1002/humu.20080
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/humu.20080
999 C 5 |a 10.1093/nar/gku989
|9 -- missing cx lookup --
|2 Crossref
|o 10.1093/nar/gku989
999 C 5 |a 10.1016/j.immuni.2012.11.018
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.immuni.2012.11.018
999 C 5 |a 10.1038/sj.cdd.4401734
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/sj.cdd.4401734


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21